Time course and cytokine dependence of human T-cell lymphotropic virus type 1 T-lymphocyte transformation as revealed by a microtiter infectivity assay

J Virol. 1995 Oct;69(10):6297-303. doi: 10.1128/JVI.69.10.6297-6303.1995.

Abstract

Human T-cell lymphotropic virus type 1 (HTLV-1) enhances the growth of T lymphocytes, allowing the generation of T-lymphocyte cell lines. This report describes a limiting-dilution assay system which uses low input numbers of HTLV-1-producing cells for generation of T-lymphocyte cultures. The HTLV-1 transformants generated with this assay system produced high levels of HTLV-1 p24 antigen and required exogenous cytokines for maintenance. Clonal populations of CD4- or CD8-positive HTLV-1 transformants were generated with transformation efficiency rates as high as 78%. An exogenous cytokine is necessary for HTLV-1 T-lymphocyte transformation, and cytokine dependence is the most likely outcome of infection and transformation. HTLV-1 T-lymphocyte transformation can occur in the presence of cytokines other than interleukin-2 (IL-2), such as IL-4 or IL-7. IL-4- or IL-7-dependent HTLV-1 transformants underwent T-lymphocyte mitogenesis in response to their homologous cytokines but proliferated best in the presence of IL-2. Since the receptors for IL-2, IL-4, and IL-7 share the IL-2 gamma chain, this component may be the common element in the signaling pathway for HTLV-1-associated transformation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / virology
  • CD8-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / virology
  • Cell Line
  • Cell Transformation, Viral*
  • Cells, Cultured
  • Clone Cells
  • Culture Techniques / methods
  • Cytokines / pharmacology*
  • Flow Cytometry
  • Gene Rearrangement, T-Lymphocyte
  • HLA-DR Antigens / analysis
  • Human T-lymphotropic virus 1 / immunology*
  • Human T-lymphotropic virus 1 / pathogenicity
  • Human T-lymphotropic virus 1 / physiology
  • Humans
  • Immunophenotyping
  • Kinetics
  • Lymphocyte Activation*
  • Reproducibility of Results
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / virology*
  • Time Factors

Substances

  • Cytokines
  • HLA-DR Antigens